FREMONT, Calif. and WALTHAM, Mass., April 29, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today announced that the Prescription Drug User Fee Act (PDUFA) date for tenapanor for the control of ...ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig. ARDELYX AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Ardelyx Inc | A116X0 | ARDX | US0396971071.ARDX | Ardelyx Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der Ardelyx Aktie Analysiere mit wallstreetONLINEConference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover ...3 days ago · Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH. 19 days ago - GlobeNewsWire.Discover Ardelyx Inc (ARDX) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityArdelyx to Participate at the 2024 Jefferies Global Healthcare Conference. WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …September 8, 2023 - 8:00 am. WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief …Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.395 subscribers in the ARDELYX community. The selective sodium hydrogen exchanger 3 (NHE3) inhibitor Tenapanor is being developed by Ardelyx Inc for…U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Healt... U.S. stock futures traded high...4 days ago · Stock analysis for Ardelyx Inc (ARDX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Greater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555To access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ...Big data is a sham. For years now, we have been told that every company should save every last morsel of digital exhaust in some sort of database, lest management lose some competi...Aug-04-23 08:29AM. Ardelyx, Inc. (NASDAQ:ARDX) Q2 2023 Earnings Call Transcript. (Insider Monkey) Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new ...Track Harbor Custom Development Inc (HCDI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors2 days ago · 9 equities research analysts have issued twelve-month price objectives for Ardelyx's shares. Their ARDX share price targets range from $8.50 to $15.00. On average, they anticipate the company's stock price to reach $12.81 in the next twelve months. This suggests a possible upside of 89.8% from the stock's current price.Get the latest Ardelyx Inc (ARDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Stock Price & Overview. Follow. 9.67K followers. $7.81 0.02 ( +0.26%) 4:00 PM 05/17/24. NASDAQ | $USD | Post-Market: $7.87 +0.06 (+0.77%) 7:57 PM. Summary. …Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on May 6, 2024, the compensation committee of the company’s board of ...Mar 5, 2024 · Ardelyx (NASDAQ:ARDX) traded higher on Tuesday after a kidney patient bill, dubbed HR-5074, moved into the markup phase in Congress, which, according to Jefferies, removed a key overhang for the ...Ardelyx (NASDAQ: ARDX) stock is climbing today after the U.S. Food and Drug Administration (FDA) approved the firm’s treatment for excessive phosphate levels in kidney disease patients. Shares ...Congress kidney patient bill. “Ardelyx (NASDAQ:ARDX) traded higher on Tuesday after a kidney patient bill, dubbed HR-5074, moved into the markup phase in Congress, which, according to Jefferies, removed a key overhang for the company's newly launched product, Xphozah.”.TipRanks9 equities research analysts have issued twelve-month price objectives for Ardelyx's shares. Their ARDX share price targets range from $8.50 to $15.00. On average, they anticipate the company's stock price to reach $12.81 in the next twelve months. This suggests a possible upside of 89.8% from the stock's current price.To access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ...Track Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMay 7, 2024 · Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Ardelyx, Inc. (Nasdaq: ARDX) announced the resignation of Dr. Geoffrey Block from the Board of Directors after nearly five years of service. Dr. Block is the Associate Chief Medical Director and Senior Vice President of Clinical Research and Medical Affairs at U.S. Renal Care. The company expressed gratitude for Dr. Block's contributions and highlighted his role in Ardelyx's evolution from a ...Choice Hotels are squarely in the mid- and lower-tier group of hotel chains. But look closer to find hidden gems. Let's take a Choice Privileges deep dive! Increased Offer! Hilton ...Ardelyx, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Ardelyx […] Insider Monkey •...Ardelyx Inc • Biotechnology Wed 22 May, close Current 1 day ago 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago 7 days ago 8 days ago 9 days ago 10 days ago 11 days ago 12 days ago 13 days ago 14 days ago 15 days ago 16 days ago 17 days ago 18 days ago 19 days ago 20 days ago 21 days ago 22 days ago 23 days ago 24 days ago 25 …Track Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the …Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.All debt owed by the company, including both long-term and short-term debt. This does not include accounts payable and similar liabilities, but may include leases depending on the analysis. $34 ...This piece of advice comes straight from a Redditor with whom many of us share similar laments: sometimes we stay up way too late messing around on the internet or watching TV, whe...Ardelyx’s first approved product, IBSRELA® (tenapanor) is available in the United States and Canada. Ardelyx is developing XPHOZAH® (tenapanor), a novel product candidate for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis, which has completed three successful Phase 3 trials.Ardelyx (ARDX) - Stocktwits Mentions. Sign up to add (ARDX) to your portfolio and access more historical data. 17 15% Est. daily mentions on Stocktwits. Sign up to access historical data. Sign up. Similar companies Company Stocktwits Mentions; Amgen AMGN: 3 25% Gilead Sciences GILD: 7 30% ...Here is how Ardelyx (ARDX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.Ardelyx released a business update Monday stating that the company expects its FDA-approved IBS treatment, Ibsrela, to achieve greater than ten percent market share at peak and generate more than ...Efavirenz: learn about side effects, dosage, special precautions, and more on MedlinePlus Efavirenz is used along with other medications to treat human immunodeficiency virus (HIV)...To access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ...9 equities research analysts have issued twelve-month price objectives for Ardelyx's shares. Their ARDX share price targets range from $8.50 to $15.00. On average, they anticipate the company's stock price to reach $12.81 in the next twelve months. This suggests a possible upside of 89.8% from the stock's current price.Ardelyx (NASDAQ:ARDX) Trading Down 3.7%. Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Robert Ora Felsch sold 207,988 shares of Ardelyx stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $8.81, for a total transaction of $1,832,374.28. Following the transaction, the insider now owns 95,947 shares of ...A typical part of morning routine—right after the “really?” side-eye I toss at my smartphone alarm—is checking to see what’s new and good on a few subreddits I care about. Imagine ...Interactive Chart for Ardelyx, Inc. (ARDX), analyze all the data with a huge range of indicators.Ardelyx is a well-funded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. This presentation is intended for investor purposes only and is not intended for promotional purposes.Apple puts a lot of emphasis on the quality of the iPhone's camera. While photos come out crisp and clear, they can also be quite large, which can cause a problem when you're sendi...View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Through extensive research, SmartAsset compiled its review of Brandywine Global Investment Management. We provide an in-depth look at the firm featuring its fees, services, investm...Interactive Chart for Ardelyx, Inc. (ARDX), analyze all the data with a huge range of indicators.Aug-04-23 08:29AM. Ardelyx, Inc. (NASDAQ:ARDX) Q2 2023 Earnings Call Transcript. (Insider Monkey) Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new ...WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in ...SEC Filings. Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference.ARDX, Ardelyx - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlinesAug-04-23 08:29AM. Ardelyx, Inc. (NASDAQ:ARDX) Q2 2023 Earnings Call Transcript. (Insider Monkey) Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new ...Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States , IBSRELA ® (tenapanor) and XPHOZAH ® (tenapanor) as well as early-stage pipeline candidates.127.89%. BEAT. Q2'23. -$0.12. -$0.08. 30.61%. BEAT. Checkout Ardelyx Inc (ARDX) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether ARDX beat the street expectations or not?The latest messages and market ideas from Dubai Trading Room (@DubaiTradingRoom) on Stocktwits. Traders Blog. Meeting place for active traders in United Arab Emirates. Stocks, Forex, Commodities, FuturesFind Ardelyx Inc (ARDX) news, corporate events, press releases, latest company updates and headlines.